|
Cows hold key to fight HIV
Deccan Chronicle “These antibodies‘ structure and their mechanism for creating diversity haven’t been seen before in other animals’ antibodies,” said Vaughn V. Smider from The Scripps Research Institute. Bovines produce unusual antibodies that are very efficient in … |
Unusual antibodies in cows suggest new ways to make therapies for peopleEureka! Science NewsHumans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study l…
BioNews TexasEpiCypher, CDI Labs Form Alliance to Develop Monoclonal Antibodies for …BioNews TexasWoodlands, Texas-based EpiCypher, Inc. and CDI Laboratories (Mayaguez, Puerto Rico) have recently signed an agreement that will enable the two companies…
Worldwide Monoclonal Antibodies Partnering Terms and Agreements Market …SBWire (press release)Albany, NY — (SBWIRE) — 06/07/2013 — The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unpreceden…
|
Unusual Antibodies in Cows Suggest New Ways to Make Medicines for People
Science Daily (press release) June 6, 2013 — Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) focusing on an … |
|
What’s Hot at EULAR 2013
Medscape “Biosimilars are on the verge of being licensed in Europe, and there will be discussions about infliximab and rituximab — the 2 most prominent ones,” said Dr. Müller-Ladner, from Justus Libig University in Giessen, Germany. The scientific program … |
Elderly patients with CLL benefit from combination therapies vs. chlorambucil …HealioStudy CLL11, presented by Goede and colleagues, examined the efficacy of treatment with GA 101 plus chlorambucil versus rituximab plus chlorambucil versus chlorambuc…
|
Obinutuzumab, rituximab improved chlorambucil efficacy in CLL
Healio CHICAGO — Response rates and survival outcomes with chlorambucil plus obinutuzumab or rituximab were superior to those with chlorambucil alone in a cohort of individuals with chronic lymphocytic leukemia, according to phase 3 study results presented … |
Cow antibodies points to new ways for making human medicinesNews-Medical.netHumans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists…
BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for …DailyFinancePre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow metastasis of lymp…